Stock data
Harmony Biosciences Holdings, Inc. (HRMY)
Harmony Biosciences Holdings, Inc. (HRMY) reported revenue of US$868.45M and net income of US$158.69M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$868.45M | US$670.11M | US$208.47M | US$158.69M | — |
| 2024 | US$714.73M | US$557.92M | US$190.83M | US$145.49M | — |
| 2023 | US$582.02M | US$460.79M | US$192.03M | US$128.85M | — |
| 2022 | US$437.86M | US$354.37M | US$120.19M | US$181.47M | — |
| 2021 | US$305.44M | US$249.92M | US$87.53M | US$34.60M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$261.28M | US$75.43M | — |
| 2026-03-31 | US$215.39M | US$32.49M | — |
| 2025-12-31 | US$243.78M | US$22.49M | — |
| 2025-09-30 | US$239.46M | US$50.87M | — |
| 2025-06-30 | US$200.49M | US$39.78M | — |
| 2025-03-31 | US$184.73M | US$45.56M | — |
| 2024-12-31 | US$201.27M | US$49.48M | — |
| 2024-09-30 | US$186.04M | US$46.09M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.